abstract |
Provided herein are hedgehog inhibitors, alone or another anticancer agent (eg, paclitaxel or paclitaxel, tyrosine kinase inhibitor (receptor tyrosine kinase (RTK) inhibitor) or mTOR inhibitor) Hedgehog ligand-dependent cancer cell growth selected from hedgehog-related cancers (eg, neuroendocrine cancers, sarcomas (eg, musculoskeletal sarcomas like chondrosarcoma and osteosarcoma)) ), Methods and compositions for treating or preventing head and neck cancer or lung cancer. |